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Purpose/Objective: Treatment planning for Stereotactic 
Body Radiation Therapy (SBRT) of liver tumours is often 
challenging due to large respiratory motion and a close 
vicinity of OARs such as great vessels and duodenum. In such 
cases a section of the PTV is edited to spare nearby OARs. We 
evaluated a PTV-less probabilistic planning technique which 
directly incorporates respiratory motion and other geometric 
uncertainties of the GTV in the dose optimization process. An 
improved balance between OAR exposure and the confidence 
of proper target dosage is expected, as well as a more 
efficient planning procedure since less human interaction is 
required. 
Materials and Methods: Four liver SBRT plans (3x20 Gy 
prescription) for which clinical planning had been 
problematic due to OAR constraints were re-planned using an 
in-house developed research plug-in for Pinnacle (version 
9.100). The plug-in combines the tumour trajectory extracted 
from the 4D planning CT (~1 cm amplitude for this case) with 
the Gaussian distribution of random errors (0.25 cm) into a 
dose blurring kernel, and incorporates a Gaussian distribution 
of systematic errors as GTV offsets (0.34 cm). Our 
probabilistic objective assumes shift invariance and aims for 
a set confidence (e.g. 90%) of GTV minimum dose. Clinical 
and probabilistic plans were compared using in-house 
software that accurately simulates the effects of motion and 
uncertainties on an optimized dose distribution by explicitly 
sampling three daily errors for each systematic error (10000 
were simulated), and 100 positions along the breathing 
trajectory for each daily error. OARs were evaluated via a 
traditional DVH. 
Results: In three out of four cases the probabilistic plan 
showed a clear clinical benefit compared to the conventional 
plan. In two cases the clinical PTV coverage was lowered to 
spare the great vessels and duodenum, here probabilistic 
planning significantly increases GTV coverage, while 
maintaining a low enough dose on the OAR (e.g. Fig. 1). In a 
third case a higher dose to the great vessels was tolerated in 
the clinical plan in favour of getting proper PTV coverage. 
Using probabilistic planning we were able to reduce the great 
vessel dose while still reaching 90% target dose confidence. 
In the fourth case all clinical constraints were met both in 
the clinical and probabilistic plan. 
Conclusions: Probabilistic planning can make a valuable 
contribution to treatment planning in those cases in which it 
is difficult to meet all clinical criteria. 
 
Figure 1. Isodose lines for a clinical (left) and probabilistic 
(right) plan. Due to the overlap of the duodenum (blue) with 
the PTV (pink line), clinical optimization was done only on 
the dashed part of the PTV, leading to reduced GTV dose 
confidence (99% of the volume received 87.5% of the dose 
with a probability of 90%). Probabilistic planning did not use 
a PTV, and led to sufficient GTV coverage (99% of the volume 
received 95% of the dose with a probability of 90%) while 
still sparing the duodenum.  
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Purpose/Objective: Stereotactic body radiation therapy 
(SBRT) is becoming the standard of care for early stage lung 
cancer patients. Toxicity data of lung injury after SBRT 
remains sparse. Our work evaluated toxicity by analyzing lung 
density changes for lung cancer patients that underwent 
SBRT. 
Materials and Methods: From 2003 to 2009, 63 patients 
received SBRT treatments in 3-5 fractions for a total median 
dose of 54Gy (range 30-60Gy). RT-induced lung density 
changes were evaluated after registration of the planning CT 
with post-RT CT scans acquired at 3, 6, 12, 18, and 24 
months after treatment. A comprehensive dose-response 
analysis was performed including 1) CT number (HU) changes 
as a function of dose, 2) spatial analysis of lung fibrosis 
location, and 3) correlation of lung tissue changes with 
clinical end-points. We generated patient specific dose-
response curves (DRC) by binning voxels into 10Gy dose bins, 
calculating the average HU for each dose bin, and evaluating 
the HU change as a function of dose. Spatial analysis was 
performed by contouring regions of fibrosis and analyzing the 
centroid movement of the fibrosis volume relative to the 
gross tumor volume (GTV) centroid. Airway or vessel 
branches inside the lung were paired on the pre- and post-RT 
scans to guide the spline based deformable registration of 
the lung. Regional density increases were classified as local 
lung collapse or fibrotic based on the local volume changes 
calculated using the deformation field Jacobian. 
Results: DRCs exhibited a linear HU increase up to 35Gy and 
a plateau beyond 35Gy. The response of the 4-5fx (high 
toxicity risk) and 3fx (lower toxicity risk) groups were notably 
different as the 4-5fx group experienced HU changes twice 
the increase seen in the 3fx group. The average radial 
movement of fibrosis centroids relative to the GTV centroids 
was 2.6 cm with movement greater than 5 cm occurring in 
11% of patients questioning the direct exposure of the 
fibrotic tissues to high doses. 30% of patients with a large 
fibrotic tissue displacement showed concurrent local lung 
volume contraction (according to the Jacobian) compatible 
with radiation-induced regional lung collapse.  
Conclusions: The current study presents a comprehensive 
dosimetric, spatial, and clinical analysis of lung density 
changes after SBRT. In addition to characterizing dose 
response after SBRT, we demonstrate certain unexpected 
observations including a dose-response plateau at 35Gy and 
fibrosis volume travel outside of the high dose region. Our 
clinical analysis suggests some of these abnormalities may be 
explained by regional lung collapse due to high SBRT doses to 
the proximal airways. Although current clinical toxicity rates 
with SBRT are low, as treatments become more aggressive, 
toxicity rates will increase and better prediction of lung 
response will be needed. Our work presents important data 
towards the mechanical and clinical understanding of lung 
injury after SBRT.  
   
 
